Steven Cohen's WST Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 235,037 shares of West Pharmaceutical Services, Inc. (WST) worth $64.67 M, representing 0.07% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 319,300 shares. Largest reduction occurred in Q4 2025, reducing 424,216 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -424,216 | Reduce 64.35% | 235,037 | $275.14 |
| Q3 2025 | +319,300 | Add 93.92% | 659,253 | $262.33 |
| Q2 2025 | +211,666 | Add 164.99% | 339,953 | $218.80 |
| Q1 2025 | -74,185 | Reduce 36.64% | 128,287 | $223.88 |
| Q4 2024 | +202,472 | New Buy | 202,472 | $327.56 |
| Q2 2024 | -112,107 | Sold Out | 0 | $0.00 |
| Q1 2024 | +4,516 | Add 4.20% | 112,107 | $395.71 |
| Q4 2023 | -76,000 | Reduce 41.40% | 107,591 | $352.12 |
| Q3 2023 | +183,591 | New Buy | 183,591 | $375.21 |
| Q2 2023 | -174,599 | Sold Out | 0 | $0.00 |
| Q1 2023 | +174,065 | Add 32596.44% | 174,599 | $346.47 |
| Q4 2022 | +534 | New Buy | 534 | $235.35 |
| Q4 2021 | -24,728 | Sold Out | 0 | $0.00 |
| Q3 2021 | -5,400 | Reduce 17.92% | 24,728 | $424.54 |
| Q2 2021 | -16,729 | Reduce 35.70% | 30,128 | $359.10 |
| Q1 2021 | +8,739 | Add 22.93% | 46,857 | $281.77 |
| Q4 2020 | -23,591 | Reduce 38.23% | 38,118 | $283.30 |
| Q3 2020 | -9,588 | Reduce 13.45% | 61,709 | $274.90 |
| Q2 2020 | +41,316 | Add 137.81% | 71,297 | $227.18 |
| Q1 2020 | -97,212 | Reduce 76.43% | 29,981 | $152.26 |
| Q4 2019 | +90,195 | Add 243.78% | 127,193 | $150.33 |
| Q3 2019 | +35,798 | Add 2983.17% | 36,998 | $141.82 |
| Q2 2019 | +1,200 | New Buy | 1,200 | $125.00 |
Steven Cohen's West Pharmaceutical Services Investment FAQs
Steven Cohen first purchased West Pharmaceutical Services, Inc. (WST) in Q2 2019, acquiring 1,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held West Pharmaceutical Services, Inc. (WST) for 23 quarters since Q2 2019.
Steven Cohen's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q3 2025, adding 659,253 shares worth $172.94 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 235,037 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $64.67 M.
As of the Q4 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.07% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in West Pharmaceutical Services, Inc. (WST) was 659,253 shares, as reported at the end of Q3 2025.